5327-91-3 Usage
General Description
4-ethoxyphenoxyacetic acid, also known as ethephon, is a plant growth regulator and a systemic ethylene-releasing compound that is commonly used in agriculture to promote fruit ripening, initiate flowering, and prevent lodging in certain crops. It is a derivative of acetic acid and acts by releasing ethylene gas, which is a natural plant hormone that stimulates various physiological processes in plants. Ethephon is also used to induce abscission, or the shedding of fruit, leaves, and flowers, making it useful in the harvesting of crops. Additionally, it has been found to have potential applications in the control of plant height and the regulation of fruit size and yield. However,
Check Digit Verification of cas no
The CAS Registry Mumber 5327-91-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,2 and 7 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5327-91:
(6*5)+(5*3)+(4*2)+(3*7)+(2*9)+(1*1)=93
93 % 10 = 3
So 5327-91-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O4/c1-2-13-8-3-5-9(6-4-8)14-7-10(11)12/h3-6H,2,7H2,1H3,(H,11,12)/p-1
5327-91-3Relevant articles and documents
ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE
-
Paragraph 0272; 0275; 0279, (2019/04/14)
Methods of treating Alzheimer's disease and other neurodegenerative and/or neurocognitive and/or neurodevelopmental diseases are described. The methods comprise the administration of compounds that modulate an activity of cell division control protein 42 (Cdc42), such as the interaction between Cdc42 and intersectin (ITSN). Exemplary modulator compounds include thioureas, disulfonamides of fused aromatic systems (e.g., benzofuran), and acyl hydrazones, among others. Some of the modulator compounds act as activators of Cdc42, while others act as inhibitors. In some cases, the modulator compound has dual functionality and the ability of the modulator compound to act as an inhibitor or activator depends on whether or not Cdc42 is already activated in a particular disease stage or biological environment by an upstream activating signal of Cdc42.